Please ensure Javascript is enabled for purposes of website accessibility

Why Teladoc Stock Plunged 12% on an Up Day for the Market

By Rich Smith - Mar 25, 2020 at 4:11PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

A formerly bullish analyst turns cautious on Teladoc.

What happened

Lawmakers in Washington appear close to finalizing a plan to begin mailing out coronavirus stimulus checks to American taxpayers -- and to unleash a flood of money, trillions of dollars in depth, to support companies that are struggling under the strain of the coronavirus. Stock markets have responded favorably to the news.

Teladoc Health (TDOC -1.94%) stock, however, is down 12% as of 3:35 p.m. EDT. What's up with that?

Red arrow swoops up and blue arrow swoops down

Image source: Getty Images.

So what

Early this morning, according to, analysts at investment bank Craig-Hallum cut their rating on Teladoc stock from buy to hold, while leaving their price target of $140 a share unchanged.

As C-H explained, Teladoc's business of telemedicine in the age of COVID-19 has become "THE (capitalization theirs, not mine) focus for investors in the stock." The implication seems to be that if and when America defeats the virus, enthusiasm for Teladoc stock might quickly wane.

Now what

Is this something investors should worry about?

Perhaps, yes. Consider that although Monday, Teladoc CEO Jason Gorevic said his people are working "around the clock" to supply demand for remote counseling using Teladoc, at last report, the company was still not profitable under generally accepted accounting principles (GAAP). (Although Teladoc did generate $26.4 million of positive free cash flow last year.) The presumed massive increase in revenue may have been enough to turn Teladoc profitable in the first quarter -- or not.

Whichever proves to be true when Teladoc next reports earnings, the fact remains that Teladoc stock has already more than tripled in value over the past year. Given all the profits the stock has produced for its investors already, C-H worries that these investors may now be tempted to use Teladoc stock as a "source of funds" -- i.e. sell Teladoc stock -- that they can then invest in stocks that have not gone up so much.

Granted, the longer the coronavirus crisis persists, the less likely that is to happen, but that's probably not a future we should be hoping for.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Teladoc Health, Inc. Stock Quote
Teladoc Health, Inc.
$34.40 (-1.94%) $0.68

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 06/29/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.